146 related articles for article (PubMed ID: 36461594)
1. Bempedoic acid, an ATP citrate lyase inhibitor, reduces intimal hyperplasia via activation of AMPKα signaling pathway.
Liu W; Liu M; Xiong H; Xia L; Yang Q; Chen M; Cai Y; Li S
Int Immunopharmacol; 2022 Dec; 113(Pt A):109392. PubMed ID: 36461594
[TBL] [Abstract][Full Text] [Related]
2. ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review.
Feng X; Zhang L; Xu S; Shen AZ
Prog Lipid Res; 2020 Jan; 77():101006. PubMed ID: 31499095
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of ARHGAP24 reduces intimal hyperplasia through inhibiting the proliferation and phenotypic switching of smooth muscle cells possibly by inactivating both AKT and ERK1/2 signaling pathways.
Liu W; Han J; Yang Q; Xia L; Chen C; Song J; Cai Y
Biochem Biophys Rep; 2024 Mar; 37():101591. PubMed ID: 38074998
[TBL] [Abstract][Full Text] [Related]
4. Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis.
Burke AC; Telford DE; Huff MW
Curr Opin Lipidol; 2019 Feb; 30(1):1-9. PubMed ID: 30586346
[TBL] [Abstract][Full Text] [Related]
5. [Role of cytokine-matrix metalloproteinase axis on promoting vascular neointima hyperplasia in mice].
Liu Y; Ning WH; Shen XH; Guo DL; Guo L
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):961-967. PubMed ID: 27903395
[No Abstract] [Full Text] [Related]
6. Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis.
Sun Q; Guo Y; Hu W; Zhang M; Wang S; Lei Y; Meng H; Li N; Xu P; Li Z; Lin H; Huang F; Qiu Z
Drug Metab Dispos; 2023 Dec; 51(12):1628-1641. PubMed ID: 37684055
[TBL] [Abstract][Full Text] [Related]
7. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia.
Burke AC; Huff MW
Curr Opin Lipidol; 2017 Apr; 28(2):193-200. PubMed ID: 28059952
[TBL] [Abstract][Full Text] [Related]
8. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
9. 10-Gingerol, a natural AMPK agonist, suppresses neointimal hyperplasia and inhibits vascular smooth muscle cell proliferation.
Deng B; Jiang XL; Xu YC; Chen S; Cai M; Deng SH; Ding WJ; Xu HL; Zhang SW; Tan ZB; Chen RX; Liu B; Zhang JZ
Food Funct; 2022 Mar; 13(6):3234-3246. PubMed ID: 35213678
[No Abstract] [Full Text] [Related]
10. Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia.
Ko DS; Kang J; Heo HJ; Kim EK; Kim K; Kang JM; Jung Y; Baek SE; Kim YH
Int J Biol Sci; 2022; 18(13):5154-5167. PubMed ID: 35982907
[TBL] [Abstract][Full Text] [Related]
11. Wild-type p53-induced phosphatase 1 promotes vascular smooth muscle cell proliferation and neointima hyperplasia after vascular injury via p-adenosine 5'-monophosphate-activated protein kinase/mammalian target of rapamycin complex 1 pathway.
Sun X; Li S; Gan X; Qiu C; Chen K; Pei H; Wang Q; Li D; Li X; Yang D; Yang Y
J Hypertens; 2019 Nov; 37(11):2256-2268. PubMed ID: 31136458
[TBL] [Abstract][Full Text] [Related]
12. Tryptanthrin Regulates Vascular Smooth Muscle Cell Phenotypic Switching in Atherosclerosis by AMP-Activated Protein Kinase/Acetyl-CoA Carboxylase Signaling Pathway.
Shi X; Zhang Y; Han J; Peng W; Fang Z; Qin Y; Xu X; Lin J; Xiao F; Zhao L; Lin Y
J Cardiovasc Pharmacol; 2021 May; 77(5):642-649. PubMed ID: 33951699
[TBL] [Abstract][Full Text] [Related]
13. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
[TBL] [Abstract][Full Text] [Related]
14. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of bempedoic acid treatment in polycystic kidney disease cells and mice.
Hallows KR; Li H; Saitta B; Sepehr S; Huang P; Pham J; Wang J; Mancino V; Chung EJ; Pinkosky SL; Pastor-Soler NM
Front Mol Biosci; 2022; 9():1001941. PubMed ID: 36504724
[TBL] [Abstract][Full Text] [Related]
17. Plantamajoside Attenuates Neointima Formation via Upregulation of Tissue Inhibitor of Metalloproteinases in Balloon-Injured Rats.
Lim L; Ki YJ; Kim H; Chu B; Choi IY; Choi DH; Song H
J Med Food; 2022 May; 25(5):503-512. PubMed ID: 35483086
[TBL] [Abstract][Full Text] [Related]
18. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
[TBL] [Abstract][Full Text] [Related]
19. The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis.
Verberk SGS; Kuiper KL; Lauterbach MA; Latz E; Van den Bossche J
Trends Mol Med; 2021 Dec; 27(12):1095-1105. PubMed ID: 34635427
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway.
Huang R; Huang Y; Zeng G; Li M; Jin Y
Cell Cycle; 2020 Apr; 19(8):918-932. PubMed ID: 32202193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
